Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial

Hereditary angioedema (HAE) is characterized by potentially life-threatening recurrent episodes of oedema. The open-label extension (OLE) phase of the For Angioedema Subcutaneous Treatment (FAST)-1 trial (NCT00097695) evaluated the efficacy and safety of repeated icatibant exposure in adults with mu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Exp Immunol
Main Authors: Malbrán, A, Riedl, M, Ritchie, B, Smith, W B, Yang, W, Banerji, A, Hébert, J, Gleich, G J, Hurewitz, D, Jacobson, K W, Bernstein, J A, Khan, D A, Kirkpatrick, C H, Resnick, D, Li, H, Fernández Romero, D S, Lumry, W
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2014
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226605/
https://ncbi.nlm.nih.gov/pubmed/24749847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12358
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki